Triple
T16011831
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Jacob Hargreave |
E388353
|
entity |
| Predicate | affiliation |
P10
|
FINISHED |
| Object |
Hargreave-Rasch Biotechnologies
Hargreave-Rasch Biotechnologies is a fictional advanced biotech corporation in the Crysis video game universe, known for its cutting-edge research into alien technology and military applications.
|
E1189431
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Hargreave-Rasch Biotechnologies | Statement: [Jacob Hargreave, affiliation, Hargreave-Rasch Biotechnologies]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Hargreave-Rasch Biotechnologies Context triple: [Jacob Hargreave, affiliation, Hargreave-Rasch Biotechnologies]
-
A.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
B.
Abraxis BioScience
Abraxis BioScience was a biopharmaceutical company best known for developing the cancer drug Abraxane and focusing on nanoparticle-based chemotherapy treatments.
-
C.
Cambridge Antibody Technology
Cambridge Antibody Technology was a pioneering UK biotechnology company best known for developing human monoclonal antibody technologies that led to blockbuster therapeutic drugs.
-
D.
Genocea Biosciences
Genocea Biosciences is a biotechnology company that develops T cell–targeted vaccines and immunotherapies using a proprietary antigen discovery platform.
-
E.
Innogen
Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Hargreave-Rasch Biotechnologies Triple: [Jacob Hargreave, affiliation, Hargreave-Rasch Biotechnologies]
Generated description
Hargreave-Rasch Biotechnologies is a fictional advanced biotech corporation in the Crysis video game universe, known for its cutting-edge research into alien technology and military applications.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Hargreave-Rasch Biotechnologies Target entity description: Hargreave-Rasch Biotechnologies is a fictional advanced biotech corporation in the Crysis video game universe, known for its cutting-edge research into alien technology and military applications.
-
A.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
B.
Abraxis BioScience
Abraxis BioScience was a biopharmaceutical company best known for developing the cancer drug Abraxane and focusing on nanoparticle-based chemotherapy treatments.
-
C.
Cambridge Antibody Technology
Cambridge Antibody Technology was a pioneering UK biotechnology company best known for developing human monoclonal antibody technologies that led to blockbuster therapeutic drugs.
-
D.
Genocea Biosciences
Genocea Biosciences is a biotechnology company that develops T cell–targeted vaccines and immunotherapies using a proprietary antigen discovery platform.
-
E.
Innogen
Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d86dabcb7c8190b6a39d6831d2fa1b |
completed | April 10, 2026, 3:25 a.m. |
| NER | Named-entity recognition | batch_69e1829119648190aef5b5e84b26d898 |
completed | April 17, 2026, 12:45 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ffcf267a9c81908f1fa1ad117c5e2c |
completed | May 10, 2026, 12:19 a.m. |
| NEDg | Description generation | batch_69ffd0bfc05881908d7223c52050ea14 |
completed | May 10, 2026, 12:26 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69ffd159dbcc81908ac586a6b8de57cf |
completed | May 10, 2026, 12:29 a.m. |
Created at: April 10, 2026, 4:55 a.m.